Alembic Pharmaceuticals Limited reported a 23 percent increase in revenues to Rs 465.2 crore for the quarter ended 31^st March 2014, compared to Rs 378.4 crores in the corresponding quarter last year.

The company posted 46 percent growth in profit before tax at Rs 80.8 crore for the quarter ended 31^st March 2014 against Rs 55.2 crore posted in the corresponding quarter last fiscal.
The net profit grew by 40 percent at Rs 61.3 crore for the quarter ended 31^st March 2014 against Rs 43.7 crores in corresponding quarter last fiscal.

EBIDTA margins for quarter ended 31^st March 2014 up at 19.6 percent to Rs 91.3 crore from 17.3 percent at Rs 65.6 crore for corresponding quarter last year.

The company also reported 22 percent increase in revenue for Year ended 31^st March 2014 to Rs 1868.4 crore against Rs 1526.0 crore for last year.

The company also posted 51 growth in profit before tax at Rs 310.6 crore for year ended 31^st March 2014 against Rs 206.4 crore for last year. The company also reported 43 percent growth in net profit for year ended 31^st March 2014 at Rs 235.5 crores against Rs 165.3 crores last year.

The Board has recommended dividend on equity shares at Rs 3.00 per share i.e. 150 percent for 13-14 (P.Y. Re. 2.50 per share i.e. 125 percent)

The India Branded formulations business posted sales of Rs 199.5 crore against Rs 175.3 crore with a 14 percent growth over the corresponding quarter of the previous year.

The India Branded formulations business posted sales for year ended 31^st March 2014 of Rs 850.6 crore against Rs 748.4 crore with a 14 percent growth over the previous year.